Eastgate Biotech Corp. (ETBI) financial statements (2020 and earlier)

Company profile

Business Address 2681 EAST PARLEYS WAY - SUITE 204
SALT LAKE CITY, UT 84109
State of Incorp. NV
Fiscal Year End December 31
SIC 6799 - Investors, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5799  73
Cash and cash equivalents5799  73
Receivables     95
Inventory, net of allowances, customer advances and progress billings113     
Inventory113     
Prepaid expense22     
Other undisclosed current assets29868   440
Total current assets:1689479  607
Noncurrent Assets
Property, plant and equipment702845   157
Long-term investments and receivables8,000     
Long-term investments8,000     
Other undisclosed noncurrent assets(7,200)    607
Total noncurrent assets:1,502845   765
Other undisclosed assets     (607)
TOTAL ASSETS:1,6701,7929  765
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,7863,3383,015280269380
Accounts payable706462424   
Accrued liabilities3,0802,8752,591   
Taxes payable   10898 
Interest and dividends payable   433395359
Other undisclosed accounts payable and accrued liabilities   (262)(225)21
Debt6366988110108
Due to related parties2,3841,6531,7052,0961,8261,564
Deferred revenue and credits (1)093961
Other liabilities96 1   
Other undisclosed current liabilities59128932,0991,9031,827
Total current liabilities:6,9615,8164,8944,5784,1043,782
Noncurrent Liabilities
Long-term debt and lease obligation, including:  40404148
Other undisclosed long-term debt and lease obligation  40404148
Total noncurrent liabilities:  40404148
Total liabilities:6,9615,8164,9344,6184,1453,830
Stockholders' equity
Stockholders' equity attributable to parent(5,291)(4,024)(4,953)(4,618)(4,145)(3,065)
Preferred stock 0    
Common stock11113333
Additional paid in capital13,21812,20410,6269,9709,8919,891
Accumulated other comprehensive income (loss)(121)58 402220
Accumulated deficit(18,399)(16,298)(15,583)(14,631)(14,062)(12,980)
Other undisclosed stockholders' equity  29   
Total stockholders' equity:(5,291)(4,024)(4,925)(4,618)(4,145)(3,065)
TOTAL LIABILITIES AND EQUITY:1,6701,7929  765

Income statement (P&L) ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Revenues23115 (94) 91
Revenue, net     91
Cost of revenue
(Cost of Goods and Services Sold)
(92)(57)   (14)
Other undisclosed gross profit(0)     
Gross profit:(69)58   77
Operating expenses(1,622)(530)(915)(628)(434)(664)
Other undisclosed operating loss   (80)  
Operating loss:(1,691)(472)(915)(707)(434)(587)
Nonoperating income (expense)5824237(227)(40)(41)
Interest and debt expense221737(43)(40)(41)
Loss from continuing operations before equity method investments, income taxes:(1,631)(13)(840)(978)(513)(670)
Other undisclosed income from continuing operations before income taxes   434041
Net loss:(1,631)(13)(840)(935)(473)(628)
Other undisclosed net loss attributable to parent(2)(702)(112)   
Net loss available to common stockholders, diluted:(1,633)(715)(952)(935)(473)(628)

Comprehensive Income ($ in thousands)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Net loss:(1,631)(13)(840)(935)(473)(628)
Other comprehensive loss(1,805)(707)(941)   
Comprehensive loss:(3,436)(720)(1,781)(935)(473)(628)
Other undisclosed comprehensive income, net of tax, attributable to parent   1654
Comprehensive loss, net of tax, attributable to parent:(3,436)(720)(1,781)(918)(469)(625)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: